Correlation Between Bristol-Myers Squibb and Allena Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Bristol-Myers Squibb and Allena Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol-Myers Squibb and Allena Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and Allena Pharmaceuticals, you can compare the effects of market volatilities on Bristol-Myers Squibb and Allena Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol-Myers Squibb with a short position of Allena Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol-Myers Squibb and Allena Pharmaceuticals.

Diversification Opportunities for Bristol-Myers Squibb and Allena Pharmaceuticals

0.0

Correlation Coefficient

Bristol-Myers Squibb  Allena Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Bristol-Myers and Allena is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Allena Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allena Pharmaceuticals and Bristol-Myers Squibb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Allena Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allena Pharmaceuticals has no effect on the direction of Bristol-Myers Squibb i.e., Bristol-Myers Squibb and Allena Pharmaceuticals go up and down completely randomly.

Pair Corralation between Bristol-Myers Squibb and Allena Pharmaceuticals

If you would invest  93,474  in Bristol Myers Squibb on December 29, 2024 and sell it today you would earn a total of  6,846  from holding Bristol Myers Squibb or generate 7.32% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Bristol Myers Squibb  vs.  Allena Pharmaceuticals

Bristol Myers Squibb

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile primary indicators, Bristol-Myers Squibb reported solid returns over the last few months and may actually be approaching a breakup point.

Allena Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Allena Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Allena Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Bristol-Myers Squibb and Allena Pharmaceuticals

The main advantage of trading using opposite Bristol-Myers Squibb and Allena Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol-Myers Squibb position performs unexpectedly, Allena Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allena Pharmaceuticals will offset losses from the drop in Allena Pharmaceuticals' long position.

The idea behind Bristol Myers Squibb and Allena Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.